Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Esteban Celis

Showing results (21-30 of 121) with videos related to

Pageof 13
Sort By:
Blood|October 5, 2010
Interferon γ limits the effectiveness of melanoma peptide vaccinesHyun-Il Cho, Young-Ran Lee, Esteban Celis
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responsesJun Lu, Yuichiro Higashimoto, Ettore Appella, et al.
Expert Review of Vaccines|October 16, 2004
T-cell epitope peptide vaccinesSherine F Elsawa, David A Rodeberg, Esteban Celis
Current Opinion in Immunology|December 13, 2016
Peptide vaccines in cancer-old concept revisitedTakumi Kumai, Hiroya Kobayashi, Yasuaki Harabuchi, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2017
Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2-4, 2016Dolores Gallardo-Rincón, Juan Pablo Marquez, Esteban Celis
Current Opinion in Immunology|July 23, 2017
Cancer immunotherapy: moving forward with peptide T cell vaccinesTakumi Kumai, Aaron Fan, Yasuaki Harabuchi, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2008
Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumorsHyun-Il Cho, Guilian Niu, Norma Bradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2014
Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumorsToshihiro Nagato, Young-Ran Lee, Yasuaki Harabuchi, et al.
Oncotarget|October 21, 2017
Effective antitumor peptide vaccines can induce severe autoimmune pathologyHussein Sultan, Jimena Trillo-Tinoco, Paulo Rodriguez, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2010
Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumorsSujin Lee, Hideo Yagita, Thomas J Sayers, et al.
Pageof 13

Showing results (21-30 of 121) with videos related to

Sort By:
Pageof 13
Blood|October 5, 2010
Interferon γ limits the effectiveness of melanoma peptide vaccinesHyun-Il Cho, Young-Ran Lee, Esteban Celis
Journal of Immunology (Baltimore, Md. : 1950)|March 23, 2004
Multiepitope Trojan antigen peptide vaccines for the induction of antitumor CTL and Th immune responsesJun Lu, Yuichiro Higashimoto, Ettore Appella, et al.
Expert Review of Vaccines|October 16, 2004
T-cell epitope peptide vaccinesSherine F Elsawa, David A Rodeberg, Esteban Celis
Current Opinion in Immunology|December 13, 2016
Peptide vaccines in cancer-old concept revisitedTakumi Kumai, Hiroya Kobayashi, Yasuaki Harabuchi, et al.
Cancer Immunology, Immunotherapy : CII|May 10, 2017
Cancer immunotherapy without frontiers: 2nd Annual Immuno-Oncology Meeting of the Centro de Investigación de Cancer en Sonora (CICS), Ciudad Obregón, Sonora México, Dec 2-4, 2016Dolores Gallardo-Rincón, Juan Pablo Marquez, Esteban Celis
Current Opinion in Immunology|July 23, 2017
Cancer immunotherapy: moving forward with peptide T cell vaccinesTakumi Kumai, Aaron Fan, Yasuaki Harabuchi, et al.
Cancer Immunology, Immunotherapy : CII|February 7, 2008
Optimized DNA vaccines to specifically induce therapeutic CD8 T cell responses against autochthonous breast tumorsHyun-Il Cho, Guilian Niu, Norma Bradley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2014
Combinatorial immunotherapy of polyinosinic-polycytidylic acid and blockade of programmed death-ligand 1 induce effective CD8 T-cell responses against established tumorsToshihiro Nagato, Young-Ran Lee, Yasuaki Harabuchi, et al.
Oncotarget|October 21, 2017
Effective antitumor peptide vaccines can induce severe autoimmune pathologyHussein Sultan, Jimena Trillo-Tinoco, Paulo Rodriguez, et al.
Cancer Immunology, Immunotherapy : CII|March 10, 2010
Optimized combination therapy using bortezomib, TRAIL and TLR agonists in established breast tumorsSujin Lee, Hideo Yagita, Thomas J Sayers, et al.
Pageof 13